FY2020 ICD-10 coding changes now in effect

October 3, 2019

With new 2020 fiscal year changes for ICD-10 coding going into effect on Oct. 1, here are a few important items for pathology and lab billers to be aware of:

  • 273 codes have been added. The majority of which comprise chapters 19 (injury, poisoning, etc) and 20 (external causes of morbidity).
  • Six new personal history codes have been added for benign and in-situ neoplasms under Z86.0. These codes should not be used as primary diagnosis codes, but may be utilized in a supporting capacity.
  • New code, R82.81, has been introduced for pyuria (white blood cells in urine).
  • R82.89 now represents abnormal findings during cytological and histological examination of urine.
  • N63, representing unspecified lump in breast, now includes additional codes for overlapping quadrants. N63.15 now represents an unspecified lump in the right breast, while N63.25 represents an unspecified lump in the left breast, both overlapping. Neither code has a distinction for gender.

Be sure to implement these changes ASAP if you haven’t done so already. If you have questions about any of the newly implemented changes, feel free to reach out to us for guidance at 517-486-4262.

Who's reviewing revenue strategy with you at this time?

Are you billing all the correct CPT codes? You’d be surprised at what you might be missing. We will review your Fee Schedule/Charge Master at no cost.

That’s right. For free.

Share This